Loading
PDBj
MenuPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

6WDP

Interleukin 12 receptor subunit beta-1

Summary for 6WDP
Entry DOI10.2210/pdb6wdp/pdb
DescriptorInterleukin-12 receptor subunit beta-1, GLYCEROL, SULFATE ION, ... (4 entities in total)
Functional Keywordscytokine receptor, signaling protein
Biological sourceHomo sapiens (Human)
Total number of polymer chains1
Total formula weight25069.71
Authors
Spangler, J.B.,Thomas, C.,Jude, K.M.,Garcia, K.C. (deposition date: 2020-04-01, release date: 2021-02-24, Last modification date: 2024-11-06)
Primary citationGlassman, C.R.,Mathiharan, Y.K.,Jude, K.M.,Su, L.,Panova, O.,Lupardus, P.J.,Spangler, J.B.,Ely, L.K.,Thomas, C.,Skiniotis, G.,Garcia, K.C.
Structural basis for IL-12 and IL-23 receptor sharing reveals a gateway for shaping actions on T versus NK cells.
Cell, 184:983-999.e24, 2021
Cited by
PubMed Abstract: Interleukin-12 (IL-12) and IL-23 are heterodimeric cytokines that are produced by antigen-presenting cells to regulate the activation and differentiation of lymphocytes, and they share IL-12Rβ1 as a receptor signaling subunit. We present a crystal structure of the quaternary IL-23 (IL-23p19/p40)/IL-23R/IL-12Rβ1 complex, together with cryoelectron microscopy (cryo-EM) maps of the complete IL-12 (IL-12p35/p40)/IL-12Rβ2/IL-12Rβ1 and IL-23 receptor (IL-23R) complexes, which reveal "non-canonical" topologies where IL-12Rβ1 directly engages the common p40 subunit. We targeted the shared IL-12Rβ1/p40 interface to design a panel of IL-12 partial agonists that preserved interferon gamma (IFNγ) induction by CD8 T cells but impaired cytokine production from natural killer (NK) cells in vitro. These cell-biased properties were recapitulated in vivo, where IL-12 partial agonists elicited anti-tumor immunity to MC-38 murine adenocarcinoma absent the NK-cell-mediated toxicity seen with wild-type IL-12. Thus, the structural mechanism of receptor sharing used by IL-12 family cytokines provides a protein interface blueprint for tuning this cytokine axis for therapeutics.
PubMed: 33606986
DOI: 10.1016/j.cell.2021.01.018
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.01 Å)
Structure validation

227111

数据于2024-11-06公开中

PDB statisticsPDBj update infoContact PDBjnumon